Molecular Surgeon Symposium on Vascular Injury, Repair

分子外科医生血管损伤、修复研讨会

• 批准号: 7057158
• 负责人: Changyi Chen
• 金额: $ 1万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-30 至 2007-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7057158
• 关键词: cardiovascular disorder therapy; cardiovascular injury; meeting /conference /symposium; molecular pathology; regeneration; travel

This R13 application requests funds to partially support the Molecular Surgeon Symposium on Vascular Injury, Repair, and Remodeling, which will be the third symposium of the Molecular Surgeon Symposium series in the Michael E. DeBakey Department of Surgery, Baylor College of Medicine. The symposium will be held at the Baylor College of Medicine, Houston, Texas, October 8 and 9, 2005. The overall goal of this interdisciplinary scientific symposium is to bring together scientists and physicians from diverse fields with a common interest in understanding vascular injury, repair, and remodeling in health and disease. It will also provide a unique opportunity for trainees (postdoctoral fellows, clinical residents and fellows, medical students, and other scientists) to interact with investigators in the field of vascular biology and vascular disease. This symposium is unique in that it will provide a forum for presenting and discussing the latest advances relevant to vascular biology and disease. This one and a half day symposium will consist of an opening keynote presentation with the following scientific sessions: 1). Advances in the molecular mechanisms of vascular disease-I: genetics, inflammation, and stem cells; 2). Advances in the molecular mechanisms of vascular disease-II: obesity, HIV, and hemodynamics; 3). Advances in the management of vascular disease-I: gene therapy, tissue engineering, and vaccination ; and 4). Advances in the management of vascular disease-II: imaging, endovascular surgery, and drug therapy. In addition, closing remarks will be given. Attendees will be invited to submit an abstract to one of three poster sections planned for the symposium that will allow all attendees, especially students, residents,,and young investigators, to present data and fully participate in discussions. We anticipate approximately 250 attendees. The limited attendance, focused scientific sessions, and highly successful poster sessions combined will provide an exciting forum for the exchange of ideas and will provide extensive opportunities for participation by a diverse group of scientists interested in vascular biology and disease. Funding is requested for planning and organizing the meeting and for travel and housing costs for speakers and those trainees selected for travel awards. Matching funds will be provided by the Institution to cover other costs. The Organizing/Scientific Committee will consist, of members from research disciplines that represent the integrated/educational concept of the Symposium. At the conclusion of the symposium, participants should be able to: 1) understand the impact of molecular biology technology on vascular research; 2) discuss recent scientific advances related to molecular pathogenesis, diagnosis, and therapy for vascular disease; 3) determine the future directions of vascular research; and 4) establish a collaborative network in vascular research. All presentations will be video-taped and presented on the "The Molecular Surgeon" website for general public access (website has been established since 1999). Furthermore, invited speakers are encouraged to submit manuscripts related to their presentations to "World Journal of Surgery" for consideration of publications. A pre-approved letter for acceptance of submission of this application from NIH/NHLBI is included.

此 R13 申请请求资金部分支持关于血管损伤、修复和重塑的分子外科医生研讨会，这将是贝勒医学院 Michael E. DeBakey 外科系分子外科医生研讨会系列的第三次研讨会。该研讨会将于 2005 年 10 月 8 日至 9 日在德克萨斯州休斯敦贝勒医学院举行。这次跨学科科学研讨会的总体目标是将来自不同领域、有共同兴趣的科学家和医生聚集在一起，以了解 健康和疾病中的血管损伤、修复和重塑。它还将为学员（博士后研究员、临床住院医师和研究员、医学生和其他科学家）提供与血管生物学和血管疾病领域的研究人员互动的独特机会。本次研讨会的独特之处在于它将提供一个展示和讨论与血管生物学和疾病相关的最新进展的论坛。 这个为期一天半的研讨会将包括开幕主题演讲和以下科学会议：1）。血管疾病分子机制研究进展-I：遗传学、炎症与干细胞； 2）。血管疾病分子机制进展-II：肥胖、HIV和血流动力学； 3）。血管疾病治疗进展-I：基因治疗、组织工程和疫苗接种；和 4)。的进展 血管疾病的治疗-II：影像学、血管内手术和药物治疗。此外，还将发表闭幕词。与会者将被邀请向研讨会计划的三个海报部分之一提交摘要，这将使所有与会者，特别是学生、居民和年轻研究人员，能够展示数据并充分参与讨论。我们预计大约有 250 名与会者。有限的出席人数，重点关注科学 会议和非常成功的海报会议相结合，将为思想交流提供一个令人兴奋的论坛，并将为对血管生物学和疾病感兴趣的不同科学家群体提供广泛的参与机会。需要资金来规划和组织会议以及演讲者和会议的旅行和住宿费用 那些被选为旅行奖励的学员。该机构将提供配套资金来支付其他费用。组织/科学委员会将由来自代表研讨会综合/教育概念的研究学科的成员组成。研讨会结束时，参与者应该能够： 1）了解分子生物学技术对血管研究的影响； 2) 讨论与血管疾病的分子发病机制、诊断和治疗相关的最新科学进展； 3）确定血管研究的未来方向； 4）建立血管研究协作网络。所有演示都会被录像 并发布在“分子外科医生”网站上供公众访问（该网站自 1999 年建立）。此外，鼓励受邀演讲者将与他们的演讲相关的手稿提交给《世界外科杂志》以供考虑出版。 其中包含 NIH/NHLBI 接受提交本申请的预先批准信函。